Literature DB >> 8596115

Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia.

A S Brown1, E S Susser, P D Butler, R Richardson Andrews, C A Kaufmann, J M Gorman.   

Abstract

Emerging evidence indicates that schizophrenia may in some cases be a neurodevelopmental disorder, resulting in part from the effects of prenatal exposures. Studies by our group have focused attention on the potential role of prenatal nutritional deficiency as a potential etiological factor. Therefore, we sought to examine the biological plausibility of prenatal nutritional deprivation in the etiopathogenesis of schizophrenia. We conducted a review of the pertinent literature. Four lines of evidence support prenatal nutritional deficiencies as a plausible set of risk factors for schizophrenia: a) their effects are not incompatible with the epidemiology of schizophrenia; b) they have adverse effects on brain development; c) general malnutrition results in neuropathological anomalies of brain regions implicated in schizophrenia; and d) prenatal malnutrition affects maternal systems critical to the developing fetal nervous system. There is sufficient evidence to warrant further studies of prenatal nutritional deficits as risk factors for schizophrenia. A strategy for testing these hypotheses is outlined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596115     DOI: 10.1097/00005053-199602000-00003

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  13 in total

1.  Detection of intergenerational genetic effects with application to HLA-B matching as a risk factor for schizophrenia.

Authors:  Erica J Childs; Eric M Sobel; Christina G S Palmer; Janet S Sinsheimer
Journal:  Hum Hered       Date:  2011-10-15       Impact factor: 0.444

Review 2.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

Review 3.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

Authors:  Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

4.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

5.  Maternal serum docosahexaenoic acid and schizophrenia spectrum disorders in adult offspring.

Authors:  Kristin N Harper; Joseph R Hibbeln; Richard Deckelbaum; Charles P Quesenberry; Catherine A Schaefer; Alan S Brown
Journal:  Schizophr Res       Date:  2011-02-15       Impact factor: 4.939

Review 6.  Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia.

Authors:  Christina G S Palmer
Journal:  J Biomed Biotechnol       Date:  2010-04-06

Review 7.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

8.  Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice.

Authors:  Francesco Matrisciano; Patricia Tueting; Ishani Dalal; Bashkim Kadriu; Dennis R Grayson; John M Davis; Ferdinando Nicoletti; Alessandro Guidotti
Journal:  Neuropharmacology       Date:  2012-04-28       Impact factor: 5.250

9.  Prenatal nutritional deficiency reprogrammed postnatal gene expression in mammal brains: implications for schizophrenia.

Authors:  Jiawei Xu; Guang He; Jingde Zhu; Xinyao Zhou; David St Clair; Teng Wang; Yuqian Xiang; Qingzhu Zhao; Qinghe Xing; Yun Liu; Lei Wang; Qiaoli Li; Lin He; Xinzhi Zhao
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

Review 10.  Environmental risk factors for psychosis.

Authors:  Kimberlie Dean; Robin M Murray
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.